Expression of CD44(+)/CD24(-), RAD6 and DDB2 on chemotherapy response in ovarian Cancer: A prospective flow cytometry study

BACKGROUNDS: Ovarian cancer is the 8th deadliest common cancer in women around the world. Almost all ovarian cancer patients would experience chemoresistance, recurrence, and poor prognosis after cytoreductive surgery and platinum-based chemotherapy. Chemoresistant cancer cells have characteristic e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sihombing, Unedo Hence Markus, Andrijono, Purwoto, Gatot, Gandamihardja, Supriadi, Harahap, Alida R., Rustamadji, Primariadewi, Kekalih, Aria, Widyawati, Retno, Fuady, Dzicky Rifqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189034/
https://www.ncbi.nlm.nih.gov/pubmed/35707599
http://dx.doi.org/10.1016/j.gore.2022.101005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189034/
https://www.ncbi.nlm.nih.gov/pubmed/35707599
http://dx.doi.org/10.1016/j.gore.2022.101005

Ejemplares similares